| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.60▼ | 1.60▼ | 1.60▼ | 1.62▼ | 1.54▲ |
| MA10 | 1.60▼ | 1.61▼ | 1.61▼ | 1.64▼ | 1.63▼ |
| MA20 | 1.62▼ | 1.61▼ | 1.63▼ | 1.55▲ | 1.57▲ |
| MA50 | 1.63▼ | 1.64▼ | 1.65▼ | 1.63▼ | 1.42▲ |
| MA100 | 1.65▼ | 1.61▼ | 1.57▲ | 1.57▲ | 1.48▲ |
| MA200 | 1.58▲ | 1.55▲ | 1.60▼ | 1.41▲ | 7.33▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.002▼ | -0.004▼ | 0.009▲ | -0.007▼ |
| RSI | 39.567▼ | 41.353▼ | 41.619▼ | 48.798▼ | 52.642▲ |
| STOCH | 38.447 | 22.468 | 23.529 | 52.154 | 36.670 |
| WILL %R | -81.818▼ | -87.500▼ | -87.500▼ | -45.000 | -58.654 |
| CCI | -157.696▼ | -127.044▼ | -131.289▼ | -10.809 | -4.072 |
|
Thursday, May 16, 2024 01:04 PM
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and ...
|
|
Thursday, May 16, 2024 10:56 AM
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024Enrollment ongoing in PIVOT-PO, a ...
|
|
Wednesday, May 15, 2024 09:55 PM
SPRO stock results show that Spero Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/05/24 | 1.615 | 1.63 | 1.575 | 1.585 | 220,164 |
| 15/05/24 | 1.60 | 1.69 | 1.60 | 1.62 | 249,503 |
| 14/05/24 | 1.64 | 1.66 | 1.60 | 1.60 | 100,011 |
| 13/05/24 | 1.67 | 1.675 | 1.66 | 1.67 | 47,132 |
| 10/05/24 | 1.72 | 1.72 | 1.61 | 1.64 | 111,384 |
| 09/05/24 | 1.66 | 1.70 | 1.65 | 1.69 | 112,672 |
| 08/05/24 | 1.66 | 1.69 | 1.63 | 1.67 | 117,765 |
| 07/05/24 | 1.67 | 1.69 | 1.65 | 1.66 | 85,469 |
| 06/05/24 | 1.67 | 1.68 | 1.64 | 1.66 | 123,496 |
| 03/05/24 | 1.63 | 1.6494 | 1.62 | 1.63 | 92,863 |
|
|
||||
|
|
||||
|
|